Notify me when Redmile Group, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 40 | $1.03B | +$21.5M | -$140M | -$119M | SRRK, KRYS, STOK, ZYME, ADCT | 13F-HR | 14 Nov 2025, 16:18 |
| Q2 2025 | 48 | $940M | +$20.6M | -$225M | -$205M | SRRK, KRYS, ZYME, STOK, IMNM | 13F-HR | 14 Aug 2025, 16:15 |
| Q1 2025 | 56 | $1.06B | +$48.5M | -$92.1M | -$43.6M | SRRK, KRYS, FOLD, ZYME, NRIX | 13F-HR | 15 May 2025, 17:00 |
| Q4 2024 | 62 | $1.43B | +$57M | -$205M | -$148M | SRRK, KRYS, NRIX, ZYME, FOLD | 13F-HR | 14 Feb 2025, 16:21 |
| Q3 2024 | 63 | $1.7B | +$43.8M | -$155M | -$111M | KRYS, NRIX, FOLD, IMNM, KYMR | 13F-HR | 14 Nov 2024, 16:15 |
| Q2 2024 | 63 | $1.65B | +$47M | -$528M | -$481M | KRYS, FOLD, NRIX, STOK, IMNM | 13F-HR | 14 Aug 2024, 16:16 |
| Q1 2024 | 76 | $2.7B | +$468M | -$878M | -$410M | KRYS, FOLD, IMNM, SRRK, FATE | 13F-HR | 15 May 2024, 16:50 |
| Q4 2023 | 68 | $2.79B | +$465M | -$319M | +$146M | IMGN, KRYS, FOLD, SRRK, RYZB | 13F-HR | 14 Feb 2024, 16:16 |
| Q3 2023 | 75 | $2.1B | +$137M | -$372M | -$235M | IMGN, KRYS, FOLD, AKRO, AUGX | 13F-HR | 14 Nov 2023, 16:15 |
| Q2 2023 | 82 | $2.61B | +$487M | -$443M | +$43.5M | IMGN, KRYS, FOLD, REPL, AKRO | 13F-HR | 14 Aug 2023, 17:15 |
| Q1 2023 | 76 | $2.3B | +$383M | -$207M | +$176M | FOLD, KRYS, ISEE, DCPH, AKRO | 13F-HR | 15 May 2023, 16:15 |
| Q4 2022 | 69 | $2.44B | +$290M | -$217M | +$72.8M | FOLD, KRYS, AKRO, REPL, FATE | 13F-HR | 14 Feb 2023, 15:18 |
| Q3 2022 | 70 | $2.58B | +$313M | -$197M | +$117M | FATE, FOLD, KRYS, ARGX, PLRX | 13F-HR | 14 Nov 2022, 15:03 |
| Q2 2022 | 71 | $2.62B | +$296M | -$100M | +$196M | FATE, FOLD, SGEN, ARGX, KRYS | 13F-HR | 15 Aug 2022, 17:22 |
| Q1 2022 | 70 | $3.2B | +$179M | -$119M | +$59.5M | FATE, FOLD, ARGX, LIVN, KRYS | 13F-HR | 16 May 2022, 16:13 |
| Q4 2021 | 71 | $4.4B | +$449M | -$636M | -$187M | FATE, FOLD, SNCE, ARGX, LIVN | 13F-HR | 14 Feb 2022, 16:07 |
| Q3 2021 | 75 | $5.73B | +$516M | -$714M | -$198M | FATE, ALLK, IGMS, ARGX, ADCT | 13F-HR | 15 Nov 2021, 16:16 |
| Q2 2021 | 86 | $6.76B | +$476M | -$812M | -$336M | FATE, IGMS, BEAM, ARGX, FOLD | 13F-HR | 16 Aug 2021, 17:00 |
| Q1 2021 | 86 | $7.1B | +$1.13B | -$1.4B | -$264M | FATE, ALLK, IGMS, ARGX, FOLD | 13F-HR | 17 May 2021, 16:05 |
| Q4 2020 | 87 | $8.26B | +$1.61B | -$274M | +$1.34B | FATE, FOLD, ALLK, BEAM, IGMS | 13F-HR | 16 Feb 2021, 15:06 |
| Q3 2020 | 80 | $5.42B | +$1.13B | -$410M | +$717M | FATE, FOLD, IMMU, ARGX, IGMS | 13F-HR | 16 Nov 2020, 15:09 |
| Q2 2020 | 79 | $5.31B | +$1.37B | -$502M | +$867M | FATE, FOLD, DCPH, ADCT, ARGX | 13F-HR | 14 Aug 2020, 16:16 |
| Q1 2020 | 69 | $3.57B | +$674M | -$177M | +$497M | FATE, FOLD, DCPH, BIIB, IGMS | 13F-HR | 15 May 2020, 16:04 |
| Q4 2019 | 64 | $4.18B | +$1.11B | -$227M | +$888M | DCPH, ALLK, FOLD, FATE, EPZM | 13F-HR | 14 Feb 2020, 15:10 |
| Q3 2019 | 74 | $2.99B | +$709M | -$69.7M | +$639M | ALLK, FOLD, FATE, DCPH, ALDR | 13F-HR | 14 Nov 2019, 15:11 |
| Q2 2019 | 81 | $3.53B | +$605M | -$295M | +$310M | ARRY, FOLD, FATE, ARGX, QURE | 13F-HR | 14 Aug 2019, 16:04 |
| Q1 2019 | 82 | $3.42B | +$662M | -$215M | +$447M | ARRY, FOLD, FATE, ATRA, ARGX | Restatement | 17 May 2019, 20:56 |
| Q4 2018 | 78 | $2.49B | +$373M | -$193M | +$180M | ARRY, ATRA, FATE, XNCR, WVE | Restatement | 16 May 2019, 15:34 |
| Q3 2018 | 83 | $3.25B | +$699M | -$208M | +$490M | ARRY, ATRA, FATE, RGNX, XNCR | Restatement | 16 May 2019, 15:34 |
| Q2 2018 | 81 | $2.94B | +$705M | -$301M | +$404M | ARRY, FOLD, ATRA, IMGN, XNCR | 13F-HR | 14 Aug 2018, 16:32 |
| Q1 2018 | 64 | $2.57B | +$569M | -$103M | +$466M | ARRY, ATRA, FOLD, IMGN, XNCR | 13F-HR | 15 May 2018, 16:30 |
| Q4 2017 | 1 | $6.6M | LIFE | New Holdings | 08 Mar 2018, 15:01 | |||
| Q4 2017 | 70 | $2.3B | +$678M | -$123M | +$555M | ARRY, FOLD, PBYI, CLVSQ, WVE | 13F-HR | 14 Feb 2018, 16:03 |
| Q3 2017 | 65 | $2.03B | +$628M | -$177M | +$451M | ARRY, FOLD, PBYI, SGENXXXX, CLVSQ | 13F-HR | 14 Nov 2017, 15:23 |
| Q2 2017 | 64 | $1.64B | +$397M | -$243M | +$154M | ARRY, FOLD, PEN, PBYI, CLVSQ | 13F-HR | 14 Aug 2017, 17:39 |
| Q1 2017 | 60 | $1.54B | +$489M | -$195M | +$295M | ARRY, PEN, FOLD, PBYI, CLVSQ | 13F-HR | 15 May 2017, 16:41 |
| Q4 2016 | 50 | $1.16B | +$246M | -$119M | +$128M | ARRY, SGENXXXX, CLVSQ, PEN, FOLD | 13F-HR | 14 Feb 2017, 15:40 |
| Q3 2016 | 51 | $1.26B | +$383M | -$187M | +$197M | ARRY, SGENXXXX, FOLD, CLVSQ, GWPH | 13F-HR | 14 Nov 2016, 17:26 |
| Q2 2016 | 53 | $1.03B | +$245M | -$177M | +$67.9M | ARRY, FOLD, MDVN, SGENXXXX, ATRA | 13F-HR | 15 Aug 2016, 18:47 |
| Q1 2016 | 47 | $977M | +$258M | -$90.2M | +$168M | FOLD, MDVN, CLVSQ, PEN, ARRY | 13F-HR | 16 May 2016, 17:22 |
| Q4 2015 | 57 | $1.34B | +$406M | -$141M | +$264M | FOLD, MDVN, PEN, ARRY, ITCI | 13F-HR | 16 Feb 2016, 15:53 |
| Q3 2015 | 58 | $1.32B | +$735M | -$51.2M | +$684M | FOLD, CLVSQ, ARRY, MDVN, INCY | Restatement | 17 Nov 2015, 14:23 |
| Q2 2015 | 55 | $1.22B | +$394M | -$172M | +$221M | ARRY, FOLD, VRX, CLVSQ, TEVA | 13F-HR | 14 Aug 2015, 16:27 |
| Q1 2015 | 54 | $1.11B | +$435M | -$117M | +$317M | ARRY, CLVSQ, FOLD, VRX, TEVA | 13F-HR | 15 May 2015, 19:11 |
| Q4 2014 | 54 | $918M | +$210M | -$93.8M | +$116M | FOLD, ARRY, VRX, CMRX, RADXXXX | 13F-HR | 17 Feb 2015, 18:28 |
| Q3 2014 | 54 | $866M | +$368M | -$135M | +$232M | VRX, B108PS, CLVSQ, CELG, FOLD | 13F-HR | 14 Nov 2014, 15:29 |
| Q2 2014 | 48 | $825M | +$336M | -$114M | +$222M | B108PS, MDTXXXX, ARRY, UHS, HCA | 13F-HR | 14 Aug 2014, 18:52 |
| Q1 2014 | 55 | $838M | +$363M | -$168M | +$194M | B108PS, HCA, A, VRX, CLVSQ | Restatement | 19 Aug 2014, 14:09 |
| Q4 2013 | 55 | $805M | GILD, CLVSQ, ZBH, CELG, AZN | 13F-HR | 14 Feb 2014, 16:16 |